drugset / Trial / NCT00896389

Salt Loading and Thiazide Intervention Study

NCT00896389

NaSingle-groupOpen-labelTreatment

Summary

The investigators of this study propose to examine the relationships between STK39 (Serine Threonine Kinase 39) genotypes and responses to salt loading and to thiazide diuretics, hydrochlorothiazide. The investigators hypothesize that STK39 genotypes will be associated with the outcome of both interventions and can contribute to personalized care for hypertension.

Timeline

Start
2009-10
Primary completion
2012-12
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrochlorothiazide Unknown 12.5 mg Oral
Subject Hydrochlorothiazide Unknown 25 mg Oral

Indications